Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+0.37%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$15.2B
AUM Growth
+$365M
Cap. Flow
+$16.5M
Cap. Flow %
0.11%
Top 10 Hldgs %
31.7%
Holding
1,372
New
93
Increased
870
Reduced
195
Closed
27

Sector Composition

1 Real Estate 55.89%
2 Technology 9.18%
3 Communication Services 4.61%
4 Consumer Discretionary 4.25%
5 Financials 3.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SMMT icon
1226
Summit Therapeutics
SMMT
$18.1B
$2K ﹤0.01%
334
+179
+115% +$1.07K
SPRO icon
1227
Spero Therapeutics
SPRO
$121M
$2K ﹤0.01%
110
+59
+116% +$1.07K
XENE icon
1228
Xenon Pharmaceuticals
XENE
$3.01B
$2K ﹤0.01%
141
+75
+114% +$1.06K
ABUS icon
1229
Arbutus Biopharma
ABUS
$776M
$1K ﹤0.01%
160
ACIU icon
1230
AC Immune
ACIU
$216M
$1K ﹤0.01%
158
AKBA icon
1231
Akebia Therapeutics
AKBA
$795M
$1K ﹤0.01%
316
ANIP icon
1232
ANI Pharmaceuticals
ANIP
$2.05B
$1K ﹤0.01%
27
APLT icon
1233
Applied Therapeutics
APLT
$69.2M
$1K ﹤0.01%
42
AVDL
1234
Avadel Pharmaceuticals
AVDL
$1.49B
$1K ﹤0.01%
120
BDTX icon
1235
Black Diamond Therapeutics
BDTX
$166M
$1K ﹤0.01%
68
CABA icon
1236
Cabaletta Bio
CABA
$145M
$1K ﹤0.01%
45
CGEN icon
1237
Compugen
CGEN
$132M
$1K ﹤0.01%
156
CLLS
1238
Cellectis
CLLS
$266M
$1K ﹤0.01%
40
CTMX icon
1239
CytomX Therapeutics
CTMX
$350M
$1K ﹤0.01%
102
DNTH icon
1240
Dianthus Therapeutics
DNTH
$817M
$1K ﹤0.01%
7
ESPR icon
1241
Esperion Therapeutics
ESPR
$518M
$1K ﹤0.01%
52
KPTI icon
1242
Karyopharm Therapeutics
KPTI
$59.9M
$1K ﹤0.01%
9
KZR icon
1243
Kezar Life Sciences
KZR
$28M
$1K ﹤0.01%
9
MGTX icon
1244
MeiraGTx Holdings
MGTX
$644M
$1K ﹤0.01%
82
NGNE icon
1245
Neurogene
NGNE
$292M
$1K ﹤0.01%
4
PAHC icon
1246
Phibro Animal Health
PAHC
$1.6B
$1K ﹤0.01%
38
PBYI icon
1247
Puma Biotechnology
PBYI
$261M
$1K ﹤0.01%
87
RIGL icon
1248
Rigel Pharmaceuticals
RIGL
$712M
$1K ﹤0.01%
37
RLMD icon
1249
Relmada Therapeutics
RLMD
$44.1M
$1K ﹤0.01%
31
RNAC icon
1250
Cartesian Therapeutics
RNAC
$265M
$1K ﹤0.01%
7